Evidence map›Paper›PMID 30081925›Full record

ReviewCell communication and signaling : CCS2018

Functional implications of Rab27 GTPases in Cancer.

Zhihong Li, Rui Fang, Jia Fang, Shasha He, Tang Liu

Open access · goldAbstract readReview
In one paragraph

Review in Cell communication and signaling : CCS, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Regulation of autophagy by Rab27B in colorectal cancer.The international journal of biochemistry & cell biology · 2024
    Article
  17. Impact of Rab27 on Melanoma Cell Invasion and sEV Secretion.International journal of molecular sciences · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Zhihong LiDepartment of Orthopaedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Rui FangDepartment of Orthopaedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jia FangDepartment of Neurology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Shasha HeDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China. heshasha611@csu.edu.cn.ORCID 0000-0002-4876-9885
Tang LiuDepartment of Orthopaedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. liutang1204@csu.edu.cn.
Central South University · CN

Funding

National Natural Science Foundation of China 81702582
6 · The paper itself

Abstract

backgroundThe Rab27 family of small GTPases promotes the progression of breast cancer, melanoma, and other human cancers. In this review, we discuss the role of Rab27 GTPases in cancer progression and the potential applications of these targets in cancer treatment. MAIN BODY: Elevated expression of Rab27 GTPases is associated with poor prognosis and cancer metastasis. Moreover, these GTPases govern a variety of oncogenic functions, including cell proliferation, cell motility, and chemosensitivity. In addition, small GTPases promote tumor growth and metastasis by enhancing exosome secretion, which alters intracellular microRNA levels, signaling molecule expression, and the tumor microenvironment.

conclusionRab27 GTPases may have applications as prognostic markers and therapeutic targets in cancer treatment.

Indexed as

AnimalsCarcinogenesisDrug Resistance, NeoplasmHumansNeoplasmsrab27 GTP-Binding Proteinsrab27 GTP-Binding ProteinsCancerExosomeRab27Small GTPaseTumor microenvironment

Identifiers

PMID30081925
PMCPMC6080553
OpenAlexW2887365181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.